Pharmacokinetics (PK) and pharmacogenomics (PGx) of ribociclib (ribo) in Black patients with metastatic breast cancer (mBC): The LEANORA study.
Year: 2024
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Donald Smith, Ilana Schlam, Cody Peer, Tristan Sissung, Keith Thomas Schmidt, Ming Tony Tan, Ami Chitalia, Nanette H. Bishopric, Seth M. Steinberg, Hyoyoung Choo-Wosoba, Christopher Gallagher, Nadia Ashai, Kristen Danielle Whitaker, Candace Bavette Mainor, Shruti Rakesh Tiwari, Nicole Swanson, Stacy K Malloy, Claudine Isaacs, William Douglas Figg, Sandra M. Swain
Institutions: Georgetown University Medical Center, Tufts Medical Center, National Institutes of Health, National Cancer Institute, Center for Cancer Research, Georgetown University, MedStar Washington Hospital Center, MedStar Georgetown University Hospital, Virginia Cancer Specialists, Georgetown Lombardi Comprehensive Cancer Center
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: closed
Awards: G1561916700, G2660551552
OpenAlex ID: W4399150422